CPSF1-Mediated Acute Myeloid Leukemia Fusion 3'UTR Alternation Is a Potential Therapeutic Target
Takahiro Shima(Moores Cancer Center), Dong‐Er Zhang(University of California San Diego), Yu Kochi(Kyushu University), Sayuri Miyauchi(UC San Diego Health System), Toshihiro Miyamoto(Kyushu University), Samuel A. Stoner(Moores Cancer Center), Junichiro Yuda(National Cancer Center Hospital East), Jiehua Zhou(University of California San Diego), Koichi Akashi(Kyushu University), Amanda G Davis(University of California San Diego), Edward D. Ball(Sheba Medical Center), D. T. Johnson(Memorial Hermann)
Cited by 1
Related Papers
MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors
|Cancer Cell|2004|701
Ipilimumab for Patients with Relapse after Allogeneic Transplantation
|New England Journal of Medicine|2016|601
Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype
|Blood|2005|456